MA26968A1 - Compositions pharmaceutiques contenant du maleate d'amlodipine. - Google Patents

Compositions pharmaceutiques contenant du maleate d'amlodipine.

Info

Publication number
MA26968A1
MA26968A1 MA27179A MA27179A MA26968A1 MA 26968 A1 MA26968 A1 MA 26968A1 MA 27179 A MA27179 A MA 27179A MA 27179 A MA27179 A MA 27179A MA 26968 A1 MA26968 A1 MA 26968A1
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
compositions containing
amlodipine maleate
containing amlodipine
maleate
Prior art date
Application number
MA27179A
Other languages
English (en)
Inventor
Jacobus Maria Lemmens
Dalen Frans Van
Arlette Vanderheijden
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740874&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26968(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MA26968A1 publication Critical patent/MA26968A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA27179A 2000-12-29 2003-05-26 Compositions pharmaceutiques contenant du maleate d'amlodipine. MA26968A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25856200P 2000-12-29 2000-12-29
US80934601A 2001-03-16 2001-03-16
AT0063401U AT5874U1 (de) 2000-12-29 2001-08-09 Pharmazeutische zubereitungen enthaltend amlodipinmaleat
BE2001/0706A BE1014449A6 (nl) 2000-12-29 2001-11-05 Farmaceutische verbindingen omvattende amlodipine maleaat.

Publications (1)

Publication Number Publication Date
MA26968A1 true MA26968A1 (fr) 2004-12-20

Family

ID=29740874

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27179A MA26968A1 (fr) 2000-12-29 2003-05-26 Compositions pharmaceutiques contenant du maleate d'amlodipine.

Country Status (27)

Country Link
US (1) US6919087B2 (fr)
EP (1) EP1309317B1 (fr)
CN (1) CN1268322C (fr)
AP (1) AP2003002819A0 (fr)
AT (3) AT5874U1 (fr)
AU (1) AU2001290354B2 (fr)
BE (1) BE1014449A6 (fr)
BR (1) BR0116556A (fr)
CA (1) CA2433035C (fr)
DE (2) DE60118008T2 (fr)
DK (3) DK1309317T3 (fr)
EA (1) EA008101B1 (fr)
ES (1) ES2258549T3 (fr)
FI (1) FI6787U1 (fr)
HK (2) HK1055904A1 (fr)
HR (1) HRP20030527A2 (fr)
IL (1) IL156691A0 (fr)
IS (1) IS6833A (fr)
MA (1) MA26968A1 (fr)
MX (1) MXPA03005883A (fr)
NO (1) NO20032517L (fr)
NZ (1) NZ526505A (fr)
PL (1) PL362668A1 (fr)
PT (1) PT1309317E (fr)
RS (1) RS53303A (fr)
UA (1) UA78500C2 (fr)
WO (1) WO2002053134A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002054062A2 (fr) * 2000-12-29 2002-07-11 Pfizer Limited Standards de reference destines a la determination de la purete ou de la stabilite de maleate d'amlodipine et procedes correspondants
MXPA03005886A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
GB0114709D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate
WO2003032954A1 (fr) * 2001-10-17 2003-04-24 Dr. Reddy's Laboratories Ltd. Formulations pharmaceutiques stabilisees contenant du maleate d'amlodipine
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
US20030153617A1 (en) * 2001-12-18 2003-08-14 Dalen Frans Van Simvastatin dosage forms
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
PT1435239E (pt) * 2002-12-31 2006-07-31 Cimex Pharma Ag Granulo estavel e facilmente processavel de maleato de amlodipina
US20050019395A1 (en) * 2003-04-14 2005-01-27 Gabor Pragai Formulations of amlodipine maleate
KR100604034B1 (ko) * 2003-10-08 2006-07-24 주식회사유한양행 암로디핀 유리염기를 함유한 구강 속붕해정 및 그의 조성물
EA013053B1 (ru) * 2004-11-05 2010-02-26 Бёрингер Ингельхайм Интернациональ Гмбх Двуслойная таблетка, содержащая телмисартан и амлодипин
EP1833466A1 (fr) * 2004-12-28 2007-09-19 Ranbaxy Laboratories Limited Procedes permettant de preparer des formes posologiques pharmaceutiques solides et stables a base d'atorvastatine et d'amlodipine
KR100825039B1 (ko) 2005-01-21 2008-04-24 대원제약주식회사 안정성이 개선된 암로디핀 말레이트염 정제
NZ561486A (en) * 2005-03-15 2011-03-31 Lupin Ltd Pharmaceutical compositions of amlodipine and benazepril
WO2007020079A2 (fr) * 2005-08-17 2007-02-22 Synthon B.V. Comprimes de simvastatine a desintegration orale
AU2005336956A1 (en) * 2005-09-28 2007-04-12 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
US8158146B2 (en) * 2005-09-28 2012-04-17 Teva Pharmaceutical Industries Ltd. Stable combinations of amlodipine besylate and benazepril hydrochloride
PT1797885E (pt) * 2005-09-28 2008-05-20 Teva Pharma Combinações estáveis de besilato de amlodipina e cloridrato de benazepril
KR100689862B1 (ko) 2005-10-04 2007-03-09 삼익제약주식회사 말레인산암로디핀을 포함하는 조성물 및 그의 제조 방법
KR100795313B1 (ko) 2006-09-05 2008-01-21 현대약품 주식회사 암로디핀 베실레이트를 포함하는 약학 조성물
CN101161241B (zh) * 2006-10-10 2010-05-26 扬子江药业集团上海海尼药业有限公司 苯磺酸氨氯地平片的制备工艺
WO2008065485A2 (fr) * 2006-10-19 2008-06-05 Torrent Pharmaceuticals Limited Compositions pharmaceutiques stables composées d'un bloqueur des canaux calcium et d'un inhibiteur ace
US20100203044A1 (en) * 2006-12-22 2010-08-12 Anatoly Nikolaev Dr6 antagonists and uses thereof in treating neurological disorders
HU230877B1 (hu) * 2008-09-30 2018-11-29 EGIS Gyógyszergyár NyR Stabil kombinációs gyógyszerkészítmény
EA020103B1 (ru) 2009-01-23 2014-08-29 Ханми Сайенс Ко., Лтд. Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
TWI461213B (zh) * 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
CN103054862B (zh) * 2013-01-08 2014-09-17 江苏万高药业有限公司 一种含有马来酸氨氯地平的快速释放的口服固体制剂
ES2886067T3 (es) 2016-10-07 2021-12-16 Silvergate Pharmaceuticals Inc Formulaciones de amlodipina
CN112334134A (zh) 2018-04-11 2021-02-05 希沃盖特制药公司 氨氯地平制剂
CN111728948A (zh) * 2020-08-19 2020-10-02 湖北潜龙药业有限公司 一种苯磺酸氨氯地平片的制备工艺

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK161312C (da) 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GB8306666D0 (en) 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (fr) 1991-09-13 1993-04-01 Merck & Co., Inc. Procede de preparation de 1,4-dihyropyridines-4-substitues
US6057344A (en) 1991-11-26 2000-05-02 Sepracor, Inc. Methods for treating hypertension, and angina using optically pure (-) amlodipine
AU3147593A (en) * 1991-11-26 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
AT399718B (de) * 1992-04-16 1995-07-25 Lek Tovarna Farmacevtskih Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
GB9317773D0 (en) * 1993-08-26 1993-10-13 Pfizer Ltd Therapeutic compound
WO1995034299A1 (fr) * 1994-06-10 1995-12-21 Telor Ophthalmic Pharmaceuticals, Inc. Inhibition du myosis/de la production de mydriase peroperatoire par des agents bloquant les canaux calciques
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
PL189666B1 (pl) 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
JP3719874B2 (ja) * 1998-04-24 2005-11-24 サンスター株式会社 口腔用組成物
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
GB0020842D0 (en) * 2000-08-23 2000-10-11 Pfizer Ltd Therapeutic compositions

Also Published As

Publication number Publication date
NO20032517D0 (no) 2003-06-04
AT7729U3 (de) 2006-01-15
AP2003002819A0 (en) 2003-06-30
EA008101B1 (ru) 2007-04-27
CA2433035A1 (fr) 2002-07-11
IS6833A (is) 2003-05-30
EP1309317A1 (fr) 2003-05-14
BE1014449A6 (nl) 2003-10-07
AU2001290354B2 (en) 2006-09-21
AT7729U2 (de) 2005-08-25
NZ526505A (en) 2005-04-29
CN1486176A (zh) 2004-03-31
US6919087B2 (en) 2005-07-19
EP1309317B1 (fr) 2006-03-15
DE60118008D1 (de) 2006-05-11
US20020176889A1 (en) 2002-11-28
IL156691A0 (en) 2004-01-04
HK1055904A1 (en) 2004-01-30
BR0116556A (pt) 2004-02-17
DE60118008T2 (de) 2006-10-26
RS53303A (en) 2006-10-27
DK1309317T3 (da) 2006-06-19
DE20116428U1 (de) 2002-01-10
FIU20030475U0 (fi) 2003-12-17
EA200300740A1 (ru) 2003-10-30
ES2258549T3 (es) 2006-09-01
FI6787U1 (fi) 2005-09-14
HK1064601A1 (en) 2005-02-04
HRP20030527A2 (en) 2005-06-30
CA2433035C (fr) 2006-04-25
WO2002053134A1 (fr) 2002-07-11
PT1309317E (pt) 2006-06-30
AT5874U1 (de) 2003-01-27
DK200300346U4 (da) 2004-04-23
MXPA03005883A (es) 2005-04-19
ATE320244T1 (de) 2006-04-15
DK200300346U1 (da) 2003-12-12
NO20032517L (no) 2003-06-20
UA78500C2 (en) 2007-04-10
CN1268322C (zh) 2006-08-09
DK200300347U3 (da) 2004-03-12
PL362668A1 (en) 2004-11-02

Similar Documents

Publication Publication Date Title
MA26968A1 (fr) Compositions pharmaceutiques contenant du maleate d'amlodipine.
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
DK200300344U4 (da) Farmaceutisk præparat indeholdende amlodipinmaleat
MA27589A1 (fr) Composes a base d'indazole, compositions pharmaceutiques et methodes pour modifier legerement ou inhiber la proliferation de cellules
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
NO20025450L (no) Ny farmasöytisk sammensetning
FR2789079B3 (fr) Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
ATE453391T1 (de) Östrogene mittel enthaltende arzneizusammensetzungen
HUP0303835A3 (en) Anti-allergic piperidine compounds, their use and pharmaceutical compositions containing them
HUP0204242A3 (en) Novel 1,3-dihydro-2h-indol-2-one derivatives, their preparation and pharmaceutical compositions compositions containing them
HUP0402003A3 (en) Substituted 1,4-benzodiazepines, pharmaceutical compositions containing them and uses thereof
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
IL161430A0 (en) Pharmaceutical compositions containing ecteinascidin 743
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
FR2833842B1 (fr) Compositions pharmaceutiques a base de derives d'azetidine
FR2812811B1 (fr) Composition pharmaceutique contenant du citalopram
IL151197A0 (en) Thiazepinyl hydroxamic acid derivatives and pharmaceutical compositions containing the same
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
IL156174A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions containing them
FR2809727B1 (fr) Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
MA26604A1 (fr) Compositions pharmaceutiques.
HUP0302255A3 (en) Sulfonamide derivatives, pharmaceutical compositions containing them and their use
MA27351A1 (fr) 1,3-diarylprop-2-en-1-ones, compositions les contenant et utilisation
IT1318654B1 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.
FR2815867B1 (fr) Compositions cosmetiques ou pharmaceutiques contenant des microcapsules thermostabilisatrices